GLPBio

Innate Immunity

Products Related to Innate Immunity(566)

  • GA20418 structure
    GA204184-Hydroxy-hippuric acid
    CAS: 2482-25-9
    Purity: >98.00%

    Polyphenol metabolite.

  • GC10929 structure
    GC10929Mastoparan X
    CAS: 72093-22-2
    Purity: >98%

    G protein activator peptide

  • GC12288 structure
    GC12288GSK-J1 sodium salt
    CAS: 1797832-71-3
    Purity: >98%

    A neuropeptide with diverse biological activities

  • GC18313 structure
    GC18313BAR501 Impurity
    CAS: 1632118-70-7
    Purity: >98%

    BAR501 impurity is an impurity found in the preparation of BAR501 that acts as an agonist of the G protein-coupled bile acid-activated receptor (GP-BAR1).

  • GC18325 structure
    GC18325Ferrichrome (iron-free)
    CAS: 34787-28-5
    Purity: >98.00%

    Ferrichrome (iron-free) est un ionophore ferrique naturel d' Ustilago sphaerogena , fourni du fer nécessaire à l'enzyme ferrochélatase.

  • GC18453 structure
    GC18453Sulochrin
    CAS: 519-57-3
    Purity: >98.00%

    Sulochrine est un métabolite fongique produit par A.

  • GC18478 structure
    GC18478MPLA
    CAS: 1246298-63-4
  • GC18487 structure
    GC18487BC-1215
    CAS: 1507370-20-8
    Purity: >99.50%

    BC-1215 est un inhibiteur de la protéine F-box 3 (Fbxo3).

  • GC18517 structure
    GC18517Diapocynin
    CAS: 29799-22-2
    Purity: >98%

    Diapocynin is the dimeric form of the NADPH oxidase inhibitor apocynin that has anti-inflammatory and antioxidant activities.

  • GC18522 structure
    GC18522Phosphatidylserines (sodium salt)
    CAS: 383908-63-2
    Purity: >95.00%

    Phosphatidylserine is a naturally occurring phospholipid that comprises 2-10% of total phospholipids in mammals and is enriched in the central nervous system, particularly the retina.

  • GC18552 structure
    GC18552Lipoxin A4
    CAS: 89663-86-5
    Purity: >95.00%

    Un acide gras trihydroxylé contenant un tétraène conjugué.

  • GC18572 structure
    GC18572Concanavalin A
    CAS: 11028-71-0

    Concanavalin A appartient aux concanamycines, une famille d'antibiotiques macrolides isolés à partir de Streptomyces diastatochromogenes qui sont les inhibiteurs très actifs et sélectifs de la proton-ATPase vacuolaire (v-[H[+]]ATPase).

  • GC18602 structure
    GC18602p38 MAPK Inhibitor IV
    CAS: 1638-41-1
    Purity: >98.00%

    p38 MAPK Inhibitor IV est un p38α compétitif pour l'ATP hautement spécifique; Inhibiteur de MAPK avec IC50 de 0,13 et 0,55 μ ; M pour p38α ; et p38β ; MAPK, respectivement.

  • GC18612 structure
    GC18612MMP-9/MMP-13 Inhibitor I
    CAS: 204140-01-2
    Purity: >98%

    MMP-9/MMP-13 inhibitor I is a cell-permeable inhibitor of matrix metalloproteinases (MMPs) that most potently inhibits MMP-9 and MMP-13 (IC50s = 0.9 nM for both).

  • GC18637 structure
    GC1863711β-Prostaglandin F2α
    CAS: 38432-87-0
    Purity: >98.00%

    11β-Prostaglandin F2α (11β-PGF2α) is the primary plasma metabolite of PGD2 in vivo.

  • GC18680 structure
    GC18680Lipoxin A4 methyl ester
    CAS: 97643-35-1
    Purity: >95.00%

    Lipoxin A4 methyl ester (LXA4 methyl ester) is a more lipid soluble, prodrug formulation of the transcellular metabolite LXA4.

  • GC18681 structure
    GC18681Lipoxin B4
    CAS: 98049-69-5
    Purity: >95.00%

    Lipoxin B4 (LXB4) is a positional isomer of LXA4 produced by the metabolism of 15-HETE or 15(S)-HpETE by human leukocytes.

  • GC18773 structure
    GC18773(Rac)-Benpyrine
    CAS: 1333714-43-4
    Purity: >99.00%

    La (Rac)-benpyrine, un racémate de la benpyrine, est un puissant inhibiteur du TNF-α actif par voie orale.

  • GC18782 structure
    GC18782CAY10657
    CAS: 494772-86-0
    Purity: >98%

    The NF-κB/Rel family of transcription factors induce and coordinate the expression of pro-inflammatory genes including cytokines, chemokines, interferons, MHC proteins, growth factors, and cell adhesion molecules.

  • GC18821 structure
    GC18821SGA360
    CAS: 680611-86-3
    Purity: >98%

    SGA360 supprime la signalisation SAA1 inflammatoire d'une manière dépendante de l'AHR par un mécanisme qui ne nécessite pas la liaison de l'AHR À son élément de réponse apparenté (antagoniste partiel) .

  • GC18835 structure
    GC18835Leukotriene A4 methyl ester
    CAS: 73466-12-3
    Purity: >97.00%

    Leukotriene A4 (LTA4) is synthesized in mast cells, eosinophils, and neutrophils from arachidonic acid by 5-lipoxygenase (5-LO), which exhibits both lipoxygenase and LTA4 synthase activities.

  • GC18856 structure
    GC18856CAY10526
    CAS: 938069-71-7
    Purity: >98.00%

    CAY10526 est un inhibiteur microsomique sp&eacute;cifique de la PGE2 synthase-1 (mPGES1). CAY10526 inhibe la production de PGE2 par la modulation s&eacute;lective de l'expression de mPGES1 mais n'affecte pas la COX-2. CAY10526 supprime de mani&egrave;re significative la croissance tumorale et augmente l'apoptose dans les x&eacute;nogreffes de m&eacute;lanome. CAY10526 r&eacute;duit les niveaux de prot&eacute;ines BCL-2 et BCL-XL (anti-apoptotique) et augmente les niveaux de BAX et BAK (pro-apoptotique) ainsi que les niveaux de caspase 3 cliv&eacute;e. CAY10526 inhibe la viabilit&eacute; cellulaire (IC50<5 μM) dans trois lign&eacute;es cellulaires de m&eacute;lanome exprimant mPGES1.

  • GC18874 structure
    GC18874Prostaglandin F2α serinol amide
    CAS: 1135226-99-1

    A stable analog of PGF 2α 2glyceryl ester

  • GC18877 structure
    GC18877CAY10606
    CAS: 1159576-98-3
    Purity: >98%

    5-Lipoxygenase (5-LO) initiates the synthesis of leukotrienes (LTs) from arachidonic acid, primarily in certain leukocyte populations.